SCHEMBL25716405

SCHEMBL25716405

C=CC(=O)Nc1cc(C)c(-c2ccc3[nH]nc(N)c3c2-c2ccc(Oc3nccc(C)n3)c(F)c2)cn1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 1/20 0.45
▸ CYP2D6 P10635 1/20 0.45
▸ FGFR1 P11362 1/20 0.45
▸ CYP2C9 P11712 1/20 0.45
▸ FGFR2 P21802 1/20 0.45
▸ FGFR4 P22455 1/20 0.45
▸ FGFR3 P22607 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ ALOX5AP P20292 4/20 0.42
▸ FEN1 P39748 4/20 0.42
▸ KDR P35968 11/20 0.39
▸ KIT P10721 5/20 0.39
▸ FLT3 P36888 5/20 0.39
▸ LCK P06239 4/20 0.39
▸ CSF1R P07333 4/20 0.39
▸ LYN P07948 4/20 0.39
▸ SRC P12931 4/20 0.39
▸ FLT1 P17948 4/20 0.39
▸ FLT4 P35916 4/20 0.39
▸ BLK P51451 4/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25715301 0.90 KDR (0.38) CYP3A4CYP2D6FGFR1CYP2C9FGFR2
SCHEMBL25716804 0.90 FGFR1 (0.48) CYP3A4CYP2D6FGFR1CYP2C9FGFR2
SCHEMBL25716455 0.90 EGFR (0.39) CYP3A4CYP2D6FGFR1CYP2C9FGFR2
SCHEMBL25718413 0.83 ALOX5AP (0.41) CYP3A4CYP2D6FGFR1CYP2C9FGFR2
SCHEMBL25715151 0.81 BTK (0.40) FGFR1KDRKITFLT3LCK
SCHEMBL25715211 0.79 LCK (0.36) KDRKITFLT3LCKCSF1R
SCHEMBL25716378 0.78 BTK (0.40) FGFR4KDRKITFLT3LCK
SCHEMBL25716441 0.77 LCK (0.36) FGFR4KDRKITFLT3LCK
SCHEMBL25714979 0.77 BTK (0.46) CYP3A4CYP2D6FGFR1CYP2C9FGFR2
SCHEMBL24772972 0.75 FGFR4 (0.53) CYP3A4CYP2D6FGFR1CYP2C9FGFR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023104035-A1 SUBSTITUTED MONOCYCLIC OR BICYCLIC HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF 英矽智能科技(上海)有限公司 2023-06-15 — — WO disclosed
Send feedback